Skip to content
Triangle logo TriangleGet started
← Study library

NCT02728804 · CITED IN SOURCE DOCUMENTS

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

An NCI or FDA source cites this study. A citation does not establish that it applies to an individual diagnosis.

Phase
Not reported
Status at capture
COMPLETED
Registry last update
2023-01-26

This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.

Open the original ClinicalTrials.gov record → · Download preserved record

What did the study report?

Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.

flow

Participant flow

→

baseline

Baseline characteristics

→

outcome · POSTED

Cumulative Incidence Rate of Treatment-related Major Financial Hardship

→

outcome · POSTED

Association of Age and Cumulative Incidence Rate of Major Financial Hardship

→

outcome · POSTED

Association of Race and Cumulative Incidence Rate of Major Financial Hardship

→

outcome · POSTED

Association of Marital Status and Cumulative Incidence Rate of Major Financial Hardship

→

outcome · POSTED

Association of Employment Status and Cumulative Incidence Rate of Major Financial Hardship

→

outcome · POSTED

Association of Income and Cumulative Incidence Rate of Major Financial Hardship

→

outcome · NOT POSTED

Health-related Quality of Life (HRQOL) as Measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) Version 3.0

→

outcome · NOT POSTED

Changes in Assets/Income/Wealth

→

outcome · NOT POSTED

Out-of-pocket Expenses, Defined as Total Out-of-pocket Direct Medical (e.g., Prescriptions, Physician Visits, Deductibles) and Non-medical (Transportation, Meals) Expenses in the 3 Months Prior to Each Study Visit

→

outcome · NOT POSTED

Changes in Health Insurance

→

outcome · NOT POSTED

Caregiver Participation

→

outcome · NOT POSTED

Accrual to a Prospective-multi-site Longitudinal Cohort Study

→

outcome · NOT POSTED

Debt and Spending by Credit Report Histories

→

outcome · NOT POSTED

Credit History (TransUnion)

→

outcome · NOT POSTED

Financial Stress (Patient, Caregiver, or Bereaved Caregiver)

→

adverse events

Adverse events

→

more info

Limitations, agreements, and source contact

→
Who could take part
eligibility Criteria
Inclusion Criteria: * Patients must have newly diagnosed metastatic colon or rectal cancer (mCRC) (de novo metastatic diagnosis) or metastatic recurrence after prior treatment for stage I-III disease and be \</= 120 days after diagnosis at time of registration * Systemic chemotherapy and/or systemic biologic therapy must be planned to be administered within 30 days after registration or must have been initiated within 60 days prior to registration; patients who are planning palliative or hospice care only (no chemotherapy or biologic therapy) are not eligible * Registering site must be an NCORP site; it is recommended that patients receive care for the mCRC at the registering site to ensure accessibility of patient records. * Patients must be able to complete questionnaires in English * Patients must provide their full name, primary address in the United States (U.S.), birth date and social security number at registration for the purposes of accessing credit report data * Patients must sign and give written informed consent in accordance with institutional and federal guidelines * As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
healthy Volunteers
false
minimum Age
18 Years
sampling Method
NON_PROBABILITY_SAMPLE
sex
ALL
std Ages
  1. ADULT
  2. OLDER_ADULT
study Population
Patients with newly diagnosed metastatic colon or rectal cancer treated at NCORP sites.
Treatment arms and interventions
arm Groups
  1. description
    Patients complete questionnaires (including the Baseline, Financial/Employment Impact, Insurance Impact, Quality of Life, and Treatment Perceptions questionnaires) over 30-60 minutes at baseline and at 3, 6, 9, and 12 months. Caregivers complete questionnaires over 30-60 minutes at baseline and at 6 and 12 months.
    intervention Names
    1. Other: Quality-of-Life Assessment
    2. Other: Questionnaire Administration
    label
    Health Services Research (questionnaire administration)
interventions
  1. arm Group Labels
    1. Health Services Research (questionnaire administration)
    description
    Complete questionnaire
    name
    Quality-of-Life Assessment
    other Names
    1. Quality of Life Assessment
    type
    OTHER
  2. arm Group Labels
    1. Health Services Research (questionnaire administration)
    description
    Complete questionnaires
    name
    Questionnaire Administration
    type
    OTHER
Study design
observational Model
COHORT
time Perspective
PROSPECTIVE
Enrollment
count
380
type
ACTUAL
Registered outcome plans (not posted results)
primary Outcomes
  1. description
    The cumulative incidence estimates of participants experiencing both major financial hardship (MFH) and multiple financial hardships will be reported. This estimate is calculated over a 12 month period; due to participant drop out throughout this period, the calculated cumulative incidence for the participants analyzed at the 12 month mark does not equate to a whole number. A major financial hardship is defined as one or more of the following: debt accumulation of any amount, selling or refinancing home, \>= 20% income decline, borrowing money of any amount from family/friends.
    measure
    Cumulative Incidence Rate of Treatment-related Major Financial Hardship
    time Frame
    Up to 12 months
secondary Outcomes
  1. description
    The cumulative incidence estimates of participants experiencing MFH within age groups. This estimate is calculated over a 12 month period; due to participant drop out throughout this period, the calculated cumulative incidence for the participants analyzed at the 12 month mark does not equate to a whole number. This is used to assess whether major financial hardship at one year differs by age (\< 65 vs. \>= 65). Age is taken at baseline.
    measure
    Association of Age and Cumulative Incidence Rate of Major Financial Hardship
    time Frame
    Up to 12 months
  2. description
    The cumulative incidence estimates of participants experiencing MFH within racial groups. This estimate is calculated over a 12 month period; due to participant drop out throughout this period, the calculated cumulative incidence for the participants analyzed at the 12 month mark does not equate to a whole number. This is used to assess whether major financial hardship at one year differs by race (white vs. non-white).
    measure
    Association of Race and Cumulative Incidence Rate of Major Financial Hardship
    time Frame
    Up to 12 months
  3. description
    The cumulative percentage of participants experiencing MFH within marital status groups. This is used to assess whether major financial hardship at one year differs by age (married vs. unmarried). Marital status is taken at baseline.
    measure
    Association of Marital Status and Cumulative Incidence Rate of Major Financial Hardship
    time Frame
    Up to 12 months
  4. description
    The cumulative incidence estimates of participants experiencing MFH within different employment status groups. This estimate is calculated over a 12 month period; due to participant drop out throughout this period, the calculated cumulative incidence for the participants analyzed at the 12 month mark does not equate to a whole number. This is used to assess whether major financial hardship at one year differs by pre-diagnosis employment status (any employment vs. unemployed). Employment status is taken at baseline.
    measure
    Association of Employment Status and Cumulative Incidence Rate of Major Financial Hardship
    time Frame
    Up to 12 months
  5. description
    The cumulative incidence estimates of participants experiencing MFH within income groups. This estimate is calculated over a 12 month period; due to participant drop out throughout this period, the calculated cumulative incidence for the participants analyzed at the 12 month mark does not equate to a whole number. This is used to assess whether major financial hardship at one year differs by household income (\<$50,000 vs. \>=$50,000 and \<$100,000 vs. \>=$100,000). Household income is taken at baseline.
    measure
    Association of Income and Cumulative Incidence Rate of Major Financial Hardship
    time Frame
    Up to 12 months
  6. description
    The relationship between major financial hardship and HRQOL will be assessed. Landmark analysis will be used to establish major financial hardship as a baseline predictor of HRQOL. In particular, patients will be categorized as having major financial hardship at their 3 month assessment (yes vs. no). Linear regression will then be used to assess whether the 3-month assessment of financial hardship predicts the 6-month HRQOL score. HRQOL at 3 months will be included as an adjustment covariate. The 6-month HRQOL score will be based on the EORTC QLQ-C30 questionnaire transformed into a linear sco
    measure
    Health-related Quality of Life (HRQOL) as Measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) Version 3.0
    time Frame
    Up to 12 months
  7. description
    Will be handled using descriptive statistics (e.g. mean, median, proportions). Descriptive statistics will be used to summarize baseline patient characteristics and will compare populations using two-sample means and proportions tests (alpha level 0.05). Caregiver strain index will be scored based on responses (score range 0 to 26). Mean scores will be compared for caregivers of patients reporting vs. not reporting at least one financial hardship.
    measure
    Changes in Assets/Income/Wealth
    time Frame
    Baseline to up to 12 months
  8. description
    Will be handled using descriptive statistics (e.g. mean, median, proportions). Descriptive statistics will be used to summarize baseline patient characteristics and will compare populations using two-sample means and proportions tests (alpha level 0.05). Caregiver strain index will be scored based on responses (score range 0 to 26). Mean scores will be compared for caregivers of patients reporting vs. not reporting at least one financial hardship.
    measure
    Out-of-pocket Expenses, Defined as Total Out-of-pocket Direct Medical (e.g., Prescriptions, Physician Visits, Deductibles) and Non-medical (Transportation, Meals) Expenses in the 3 Months Prior to Each Study Visit
    time Frame
    Up to 12 months
  9. description
    Will be handled using descriptive statistics (e.g. mean, median, proportions). Descriptive statistics will be used to summarize baseline patient characteristics and will compare populations using two-sample means and proportions tests (alpha level 0.05). Caregiver strain index will be scored based on responses (score range 0 to 26). Mean scores will be compared for caregivers of patients reporting vs. not reporting at least one financial hardship.
    measure
    Changes in Health Insurance
    time Frame
    Baseline to up to 12 months
  10. description
    The caregiver component will be considered feasible if the designated caregivers for \> 50% of eligible patients complete and submit their baseline and at least one follow-up assessment. Means, medians, and proportions will be used to describe the participating caregiver population. Analyses will be largely descriptive. If caregiver accrual is very poor (\< 20%), describing the patient population will be the focus rather than attempting to correlate caregiver and patient responses.
    measure
    Caregiver Participation
    time Frame
    Up to 12 months
  11. description
    Each of the NCORP components (we anticipate 25 NCORP components) will each need to enroll, on average, about 5 patients per year. Accrual will be assessed at 1.5 years after study activation. If monthly average accrual in quarters 5-6 after study registration is \< 50% of projected accrual, efforts will be made to increase accrual over the succeeding 6 month period. If after 2 years, monthly accrual remains \< 50% of projected accrual, study revision will be considered. In order to address the potential for selection bias, demographics (age, race, gender, etc.) of the final cohort will be compared
    measure
    Accrual to a Prospective-multi-site Longitudinal Cohort Study
    time Frame
    Up to 3 years
  12. description
    Credit histories obtained from TransUnion measure the following: non-mortgage amounts past due on credit cards and bankcards; non-mortgage credit card and bankcard balances; bankruptcies, liens, collections or repossessions. Will be handled using descriptive statistics (e.g. mean, median, proportions). Descriptive statistics will be used to summarize baseline patient characteristics and will compare populations using two-sample means and proportions tests (alpha level 0.05). Caregiver strain index will be scored based on responses (score range 0 to 26). Mean scores will be compared.
    measure
    Debt and Spending by Credit Report Histories
    time Frame
    Up to 12 months
Full study description
brief Summary
This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.
detailed Description
PRIMARY OBJECTIVES: I. To estimate the incidence of treatment-related major financial hardship over 12 months, among patients with newly diagnosed metastatic colorectal cancer (mCRC) treated at components and subcomponents of the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). SECONDARY OBJECTIVES: I. To describe the association of major financial hardships with mCRC treatment by demographic factors, including age, race, marital status, employment status, and income. II. To explore whether occurrence of major financial hardship is associated with poorer health-related quality of life over time. III. To profile the magnitude and timing of treatment-related changes in patients' income, assets, debt, and employment, and to quantify major out-of-pocket expenses during the 12 months following registration. IV. To explore the extent to which health insurance factors (e.g. high copayments, deductibles, premiums, loss/change of insurance plan) are associated with major financial hardship and treatment non-adherence. V. To determine feasibility of recruiting primary caregivers and measuring caregiver burden and caregivers' perceptions about cancer treatment costs. VI. To determine the feasibility of conducting a prospective-multi-site longitudinal cohort study assessing financial outcomes in patients with mCRC undergoing treatment within the NCORP network. TERTIARY OBJECTIVES: I. To obtain objective measures of expenses, debt and credit through linkage with individual patient credit reports (TransUnion) at enrollment (baseline) and end of follow up (12 months). OUTLINE: Patients complete questionnaires (including the Baseline, Financial/Employment Impact, Insurance Impact, Quality of Life, and Treatment Perceptions questionnaires) over 30-60 minutes at baseline and at 3, 6, 9, and 12 months. Caregivers complete questionnaires over 30-60 minutes at baseline and at 6 and 12 months.
Source references
Source notices and limitations
    Discovery and provenance
    1. release id
      ctgov-registry-7ad944f6deaf1f5cd6122126
      edge id
      nct-edge-c1ad25c486c793881cfa
      requested nct id
      NCT02728804
      primary nct id
      NCT02728804
      source kind
      nci_explicit_reference_or_link
      source record id
      Source null
      source file sha256
      c247b59913fc3955acb2c9c7e43c7964f12ceb43f77976c3681fd4c55345155a
      payload sha256
      59e560fbc5a56b3528d7ec521abbd750971e981803564c346cf5c093f3502168
      payload
      clinical indication matching status
      not_inferred
      end exclusive
      true
      id
      nct-edge-c1ad25c486c793881cfa
      link basis
      explicit_NCT_identifier_in_acquired_source
      nct id
      NCT02728804
      occurrences
      1. context exact
        li> The impact of counseling techniques to manage finances.</li></ul></div> <p id="_160" tabindex="-1">One prospective study (<a href="/clinicaltrials/NCT02728804">S1417CD</a> [NCT02728804]), conducted in the National Cancer Institute Cooperative Cancer Clinical Trials Network, <em>Implementation of a Prospective Financ
        end
        135881
        exact text
        NCT02728804
        start
        135870
      2. context exact
        ing techniques to manage finances.</li></ul></div> <p id="_160" tabindex="-1">One prospective study (<a href="/clinicaltrials/NCT02728804">S1417CD</a> [NCT02728804]), conducted in the National Cancer Institute Cooperative Cancer Clinical Trials Network, <em>Implementation of a Prospective Financial Impact Assessment Tool
        end
        135907
        exact text
        NCT02728804
        start
        135896
      offset unit
      unicode_code_points
      source file
      /tmp/cancer-full-research/nci/raw/8b777c375c5e857b94.html
      source file sha256
      c247b59913fc3955acb2c9c7e43c7964f12ceb43f77976c3681fd4c55345155a
      source json pointer
      Source null
      source kind
      nci_explicit_reference_or_link
      source record id
      Source null
      source retrieved at
      2026-09-09T23:21:27.710047+00:00
      source string basis
      UTF-8_text_with_universal_newline_translation
      source string sha256
      eef8ca814d3446ddf0dbfdada5fc80deaffddb8e2d3520370def6c89d8238f63
      source title
      Financial Toxicity and Cancer Treatment (PDQ®)–Health Professional Version
      source update dates
      1. context
        Updated: May 29, 2024
        datetime
        2024-05-29T12:00:00Z
        display
        May 29, 2024

    Preserved source evidence · Not medical advice